(MENAFN- PR Newswire)
DUBLIN, Jan. 14, 2022 /PRNewswire/ -- The 'Ophthalmology Market Research Report by Diseases, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19' report has been added to ResearchAndMarkets.com's offering.
The Global Ophthalmology Market size was estimated at USD 52.07 billion in 2020, is expected to reach USD 55.28 billion in 2021, and is projected to grow at a CAGR of 6.52% to reach USD 81.05 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ophthalmology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Ophthalmology Market, including Alcon, Alkeus Pharmaceuticals, Bausch + Lomb, Carl Zeiss AG, ClearSight, CooperVision, Envisia Therapeutics, Essex Bio, EssilorLuxottica, Eyenovia, Gensight Biologics, Glaukos Corp, Hoya Corporation, Iris Pharma, Johnson & Johnson Vision, Kubota Pharmaceuticals, LC Technologies, NIDEK CO., LTD., Oraya Therapeutics, PanOptica, PharmOptima, Sensimed, ThromboGenics, Topcon, Topivert, Unimed Pharma, Vision Medicines, VisionCare, and Wellstat Group. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Ophthalmology Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ophthalmology Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ophthalmology Market?4. What is the competitive strategic window for opportunities in the Global Ophthalmology Market?5. What are the technology trends and regulatory frameworks in the Global Ophthalmology Market?6. What is the market share of the leading vendors in the Global Ophthalmology Market?7. What modes and strategic moves are considered suitable for entering the Global Ophthalmology Market? Key Topics Covered: 1. Preface 2. Research Methodology 3. Executive Summary 4. Market Overview 5. Market Insights 5.1. Market Dynamics5.1.1. Drivers5.1.1.1. Increasing geriatric population globally5.1.1.2. Availability of well-established healthcare infrastructure5.1.1.3. Rising eye-care issues attributed to changing lifestyles worldwide5.1.2. Restraints5.1.2.1. High cost of treatment5.1.3. Opportunities5.1.3.1. Surge in research and development to provide new treatment5.1.3.2. Ongoing production of novel therapeutic drugs for treatment of eye diseases5.1.4. Challenges5.1.4.1. Dearth of skilled professionals5.2. Cumulative Impact of COVID-19 6. Ophthalmology Market, by Diseases 6.1. Introduction6.2. Age-Related Macular Degeneration6.3. Cataract6.4. Glaucoma6.5. Inflammatory Diseases6.6. Others6.7. Refractive Disorders 7. Ophthalmology Market, by End User 7.1. Introduction7.2. Healthcare Service Providers7.3. Hospitals7.4. Medical Institutes7.5. Research Organizations 8. Americas Ophthalmology Market 8.1. Introduction8.2. Argentina8.3. Brazil8.4. Canada8.5. Mexico8.6. United States 9. Asia-Pacific Ophthalmology Market 9.1. Introduction9.2. Australia9.3. China9.4. India9.5. Indonesia9.6. Japan9.7. Malaysia9.8. Philippines9.9. Singapore9.10. South Korea9.11. Taiwan9.12. Thailand 10. Europe, Middle East & Africa Ophthalmology Market 10.1. Introduction10.2. France10.3. Germany10.4. Italy10.5. Netherlands10.6. Qatar10.7. Russia10.8. Saudi Arabia10.9. South Africa10.10. Spain10.11. United Arab Emirates10.12. United Kingdom 11. Competitive Landscape 11.1. FPNV Positioning Matrix11.1.1. Quadrants11.1.2. Business Strategy11.1.3. Product Satisfaction11.2. Market Ranking Analysis11.3. Market Share Analysis, By Key Player11.4. Competitive Scenario11.4.1. Merger & Acquisition11.4.2. Agreement, Collaboration, & Partnership11.4.3. New Product Launch & Enhancement11.4.4. Investment & Funding11.4.5. Award, Recognition, & Expansion 12. Company Usability Profiles 12.1. Alcon12.2. Alkeus Pharmaceuticals12.3. Bausch + Lomb12.4. Carl Zeiss AG12.5. ClearSight12.6. CooperVision12.7. Envisia Therapeutics12.8. Essex Bio12.9. EssilorLuxottica12.10. Eyenovia12.11. Gensight Biologics12.12. Glaukos Corp12.13. Hoya Corporation12.14. Iris Pharma12.15. Johnson & Johnson Vision12.16. Kubota Pharmaceuticals12.17. LC Technologies12.18. NIDEK CO., LTD.12.19. Oraya Therapeutics12.20. PanOptica12.21. PharmOptima12.22. Sensimed12.23. ThromboGenics12.24. Topcon12.25. Topivert12.26. Unimed Pharma12.27. Vision Medicines12.28. VisionCare12.29. Wellstat Group 13. Appendix
For more information about this report visit
Media Contact:
Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
MENAFN14012022003732001241ID1103541269
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.